Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer is a phase 2, randomised interventional study registered as NCT07095309 by Metanoic Health Ltd., with a registry enrolment figure of 120 participants, started 2025-08-15 and due to reach its primary completion in 2032-08-30. Interventions recorded: Artesunate; Artesunate matching Placebo. Conditions listed: Stage II/III Colon Cancer; Bowel Cancer. Primary outcome: Recurrence-Free Survival (RFS) at 2 Years Post-Randomisation Assessed by Radiological and Clinical Evaluation. Colorectal eligibility wording from the registry: "* Histologically proven single primary site colorectal adenocarcinoma or high grade dysplasia plus unequivocal radiological evidence of invasive cancer". Sites: Malaysia. No results are recorded here; the registry entry is the source.